Sight Sciences, Inc. (SGHT)
8.365
-0.06
(-0.65%)
USD |
NASDAQ |
Sep 03, 10:01
Sight Sciences Debt to Equity Ratio : 0.7935 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7935 |
| March 31, 2026 | 0.7586 |
| December 31, 2025 | 0.6377 |
| September 30, 2025 | 0.6328 |
| June 30, 2025 | 0.5795 |
| March 31, 2025 | 0.5212 |
| December 31, 2024 | 0.4612 |
| September 30, 2024 | 0.3716 |
| June 30, 2024 | 0.3446 |
| March 31, 2024 | 0.3206 |
| December 31, 2023 | 0.2946 |
| September 30, 2023 | 0.2729 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.2555 |
| March 31, 2023 | 0.2383 |
| December 31, 2022 | 0.2185 |
| September 30, 2022 | 0.1985 |
| June 30, 2022 | 0.1788 |
| March 31, 2022 | 0.1616 |
| December 31, 2021 | 0.1474 |
| September 30, 2021 | 0.1388 |
| June 30, 2021 | -1.278 |
| March 31, 2021 | -1.486 |
| December 31, 2020 | -1.686 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Integra LifeSciences Holdings Corp. | 1.964 |
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 104.87M |
| Total Liabilities (Quarterly) | 51.98M |
| Shareholders Equity (Quarterly) | 52.89M |
| Current Ratio | 4.948 |
| Net Debt Paydown Yield | -0.10% |